, November 2022 — Base-editing-mediated dissection of a \gamma-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression. Nature Communications vol. 13, n° 1, dir. {Nature Publishing Group} p. 6618
, June 2022 — Disease modeling by efficient genome editing using a near PAM-less base editor in vivo. Nature Communications vol. 13, n° 1, dir. {Nature Publishing Group} p. 3435
, October 2021 — Recent Progress in Genome Editing for Gene Therapy Applications: The French Perspective. Human Gene Therapy vol. 32, 19-20, dir. {Mary Ann Liebert} p. 1059-1075
, February 2020 — Editing a \gamma-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype. Science Advances vol. 6, n° 7, dir. {American Association for the Advancement of Science (AAAS)} eaay9392
, 2019 — Differential Requirements for the RAD51 Paralogs in Genome Repair and Maintenance in Human Cells. PLoS Genetics vol. 15, n° 10, dir. {Public Library of Science} e1008355
, December 2018 — High doses of CRISPR/Cas9 ribonucleoprotein efficiently induce gene knockout with low mosaicism in the hydrozoan Clytia hemisphaerica through microhomology-mediated deletion. Scientific Reports vol. 8, n° 1, dir. {Nature Publishing Group}
, 2018 — Generation of Immunodeficient Rats With Rag1 and Il2rg Gene Deletions and Human Tissue Grafting Models. Transplantation vol. 102, n° 8, dir. {Lippincott, Williams \& Wilkins} p. 1271-1278
, November 2017 — Generation of gene-edited rats by delivery of CRISPR/Cas9 protein and donor DNA into intact zygotes using electroporation. Scientific Reports vol. 7, n° 1, dir. {Nature Publishing Group} p. 16554
, March 2016 — Improved Genome Editing Efficiency and Flexibility Using Modified Oligonucleotides with TALEN and CRISPR-Cas9 Nucleases.. Cell Reports vol. 14, n° 9, dir. {Elsevier Inc} p. 2263-72
, 2016 — « Genome Editing in Rats Using TALE Nucleases » in TALENs. Methods in Molecular Biology.. , , p. 245-259
, December 2015 — Genome Editing and Dialogic Responsibility: “What’s in a Name?”. American Journal of Bioethics vol. 15, n° 12, dir. {Taylor \& Francis (Routledge)} p. 54-57
, October 2015 — Homology-directed repair in rodent zygotes using Cas9 and TALEN engineered proteins. Scientific Reports vol. 5, , dir. {Nature Publishing Group} p. 14410
, August 2014 — Efficient gene targeting by homology-directed repair in rat zygotes using TALE nucleases. Genome Research vol. 24, n° 8, dir. {Cold Spring Harbor Laboratory Press} p. 1371-1383
, August 2014 — Gene targeting in rats using transcription activator-like effector nucleases. Methods vol. 69, n° 1, dir. {Elsevier} p. 102-107
, 2014 — Characterization of Dystrophin Deficient Rats: A New Model for Duchenne Muscular Dystrophy. PLoS ONE vol. 9, n° 10, dir. {Public Library of Science} 13 p.
, July 2008 — Triplex-forming oligonucleotide-orthophenanthroline conjugates for efficient targeted genome modification.. Proceedings of the National Academy of Sciences of the United States of
America vol. 105, n° 28, dir. {National Academy of Sciences} p. 9576-81